Brevan Howard Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19,005	Closed	-$745K	–	1460
2024 Q4	$745K	Buy	19,005 +6,993	+58%	+$274K	﹤0.01%	479
2024 Q3	$473K	Buy	+12,012	New	+$473K	﹤0.01%	641